Alkem Laboratories Limited (BOM:539523)
India flag India · Delayed Price · Currency is INR
5,390.90
+240.25 (4.66%)
At close: Aug 13, 2025

Alkem Laboratories Company Description

Alkem Laboratories Limited, a pharmaceutical company, engages in the research and development, manufacture, and sale of pharmaceutical and nutraceutical products in India, the United States, and internationally.

The company offers branded generics, generic drugs, active pharmaceutical ingredients, and biosimilars, and nutraceuticals in acute and chronic therapeutic areas comprising anti-infective, gastroenterology, pain management, iron deficiency, diabetology, central nervous system, anti-osteoporosis, gynecology, respiratory, ophthalmology, rheumatology, urology, dermatology, cardiology, neurology, and oncology.

It also provides vitamins, minerals, and nutrients; cough syrups, hepatoprotective tonic, anti-dandruff shampoo, mouth wash, pregnancy detection kits, and condoms; and anti-bloating syrups, tablets, and powder.

The company was incorporated in 1973 and is headquartered in Mumbai, India.

Alkem Laboratories Limited
Country India
Founded 1973
Industry Pharmaceutical Preparations
Employees 18,785
CEO Vikas Gupta

Contact Details

Address:
Alkem House
Mumbai, 400013
India
Phone 91 22 3982 9999
Website alkemlabs.com

Stock Details

Ticker Symbol 539523
Exchange Bombay Stock Exchange
Fiscal Year April - March
Reporting Currency INR
SIC Code 2834

Key Executives

Name Position
Vikas Gupta Chief Executive Officer
Nitin Agrawal Chief Financial Officer
Satish Singh Chief Operating Officer
Purvi Shah Head of Investor Relations